Adults with type 2 diabetes may have a higher risk for developing nonarteritic anterior ischemic optic neuropathy while using ...

Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...

The Biden-era law is now in the hands of a new administration, and drugmakers are scanning the horizon for hints of a massive ...

Merck's full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 billion.

Key Takeaways Merck shares fell sharply Tuesday morning after the drugmaker's profits and 2025 outlook fell short of estimates.Revenue and adjusted earnings, however, managed to top expectations.Sales ...

That news sent the company’s stock down more than 10% in early morning trading ... in 2024 was partially offset by lower sales of JANUVIA and JANUMET, primarily reflecting lower pricing in ...

Latest evidence has unveiled some “unrecognised benefits and risks of glucagon-like peptide-1 receptor agonists (GLP-1RA)”. A new study led by Washington University School of Medicine has demonstrated ...

She said: “With nutrition, there is no all or nothing. Erectile dysfunction can be triggered by eating spicy food Eating disorders among children doubled in under 10 years Popular fasting diet more ...